T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.45 SGD Market Closed
Market Cap: 597.4m SGD
Have any thoughts about
Talkmed Group Ltd?
Write Note

Talkmed Group Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Talkmed Group Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
P8A
QC7
5NG
1B1
EUDA

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
T
Talkmed Group Ltd
SGX:5G3
Cash & Cash Equivalents
S$85.7m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Cordlife Group Ltd
SGX:P8A
Cash & Cash Equivalents
S$17.4m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-6%
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Cash & Cash Equivalents
S$34m
CAGR 3-Years
-11%
CAGR 5-Years
6%
CAGR 10-Years
2%
Healthway Medical Corporation Ltd
SGX:5NG
Cash & Cash Equivalents
S$18.6m
CAGR 3-Years
-8%
CAGR 5-Years
-12%
CAGR 10-Years
13%
HC Surgical Specialists Ltd
SGX:1B1
Cash & Cash Equivalents
S$7.4m
CAGR 3-Years
-12%
CAGR 5-Years
8%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Cash & Cash Equivalents
$189k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Talkmed Group Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
85.7m SGD

Based on the financial report for Jun 30, 2024, Talkmed Group Ltd's Cash & Cash Equivalents amounts to 85.7m SGD.

What is Talkmed Group Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
3%

Over the last year, the Cash & Cash Equivalents growth was 6%. The average annual Cash & Cash Equivalents growth rates for Talkmed Group Ltd have been 2% over the past three years , 3% over the past five years .

Back to Top